Ian Gering

发表

A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant

J. van den Heuvel, D. Willbold, Jeannine Mohrlüder, 2022, Journal of virology.

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease

K. Langen, N. Shah, D. Willbold, 2018, Journal of Alzheimer's disease : JAD.

Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation.

H. Stark, D. Willbold, A. Zivkovic, 2021, Bioorganic & medicinal chemistry.

Towards the mode of action of the clinical stage all-D-enantiomeric peptide RD2 on Aβ42 aggregation.

D. Willbold, Tao Zhang, L. Nagel-Steger, 2019, ACS chemical neuroscience.

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Pitter F. Huesgen, L. Pollegioni, S. Sacchi, 2019, Scientific Reports.

Evaluation of the 18F-Labeled Analog of the Therapeutic All-d-enantiomeric Peptide RD2 for Amyloid β Imaging.

K. Langen, H. Endepols, B. Neumaier, 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Tau protein aggregation associated with SARS-CoV-2 main protease

M. Coronado, K. Stühler, D. Willbold, 2023, bioRxiv.

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro

M. Coronado, D. Willbold, R. Arni, 2021, Viruses.

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1G93A Transgenic Mice

N. Shah, K. Langen, S. Hartwig, 2021, International journal of molecular sciences.

Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease

Nils‐Alexander Lakomek, M. Coronado, B. Strodel, 2023, ACS chemical biology.

Oral absorption enhancement of the amyloid-β oligomer eliminating compound RD2 by conjugation with folic acid.

C. Zafiu, Markus Tusche, B. Santiago-Schübel, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo

Anne K. Braczynski, D. Willbold, W. Hoyer, 2022, Biomolecules.

Conversion rate to the secondary conformation state in the binding mode of SARS-CoV-2 spike protein to human ACE2 may predict infectivity efficacy of the underlying virus mutant

J. van den Heuvel, D. Willbold, Jeannine Mohrlüder, 2021, bioRxiv.

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

Pitter F. Huesgen, L. Pollegioni, S. Sacchi, 2019, Scientific Reports.

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies

D. Willbold, W. Hoyer, Markus Tusche, 2023, International journal of molecular sciences.

Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

M. Coronado, D. Willbold, R. Arni, 2021, bioRxiv.

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease

D. Willbold, A. Willuweit, L. C. Camargo, 2021, International journal of molecular sciences.